These in vivo studies further demonstrated that HSPC/DSPE-mPEG2000/Cholesterol/CA4 nanoliposomes significantly reduce tumor growth when compared to free CA4 without significant weight loss in the mice, revealing excellent antitumor efficacy against breast cancer with no side effects [36]. The gene discussed is CA4; the disease is neoplasm.